object
clinic
characterist
chest
imag
find
viral
pneumonia
sever
interstiti
lung
diseas
ild
overlap
viral
pneumonia
may
underrecogn
misdiagnos
certain
ild
clarifi
frequenc
viral
pneumonia
among
patient
acut
progress
clinic
cours
requir
differenti
diagnosi
ild
pneumonia
determin
frequent
ild
misdiagnos
case
viral
pneumonia
retrospect
analyz
patient
hospit
acut
clinic
cours
day
underw
bronchoalveolar
lavag
bal
differenti
diagnosi
infect
ild
perform
multiplex
pcr
respiratori
virus
use
patient
preserv
bal
fluid
final
diagnosi
made
multidisciplinari
approach
consid
pcr
result
diagnosi
discharg
compar
final
diagnosi
result
among
patient
diagnos
viral
pneumonia
viral
pneumonia
diseas
show
differ
symptom
laboratori
data
howev
differ
small
overlap
viral
pneumonia
misdiagnos
discharg
acut
fibrin
organ
pneumonia
cryptogen
organ
pneumonia
chronic
eosinophil
pneumonia
afopcopcep
acut
interstiti
pneumonia
connect
tissu
diseaserel
ild
unclassifi
interstiti
pneumonia
druginduc
ild
pneumonia
conclus
approxim
half
patient
underw
bal
viral
pneumonia
common
ildrel
misdiagnos
afopcopcep
differ
symptom
laboratori
find
viral
pneumonia
diseas
small
viral
pneumonia
includ
differenti
diagnosi
physician
encount
case
abovement
ild
suspect
communityacquir
pneumonia
lead
caus
mortal
worldwid
diagnosi
treatment
tradit
focus
bacteri
pathogen
recent
nucleic
acid
amplif
test
use
polymeras
chain
reaction
pcr
platform
greatli
improv
diagnosi
respiratori
viral
infect
thu
recogn
intern
med
doi
monli
accompani
cough
fever
occasion
flulik
symptom
also
overlap
symptom
viral
pneumonia
thu
consid
patient
viral
pneumonia
may
misdiagnos
certain
ild
whenev
viru
survey
perform
object
present
studi
clarifi
mani
patient
viral
pneumonia
misdiagnos
diseas
includ
ild
determin
ild
frequent
misdiagnos
base
pcr
detect
virus
bronchoalveolar
lavag
fluid
balf
retrospect
analyz
patient
admit
saitama
cardiovascular
respiratori
center
januari
decemb
whose
differenti
diagnosi
includ
acut
progress
day
ild
pneumonia
patient
provid
diagnosi
discharg
hospit
period
respiratori
physician
licens
japanes
respiratori
societi
perform
bal
accord
convent
method
patient
differenti
diagnosi
obtain
balf
transport
dri
ice
store
use
detect
respiratori
pathogen
rotorgen
q
instrument
quiagen
hilden
germani
multiplex
realtim
pcr
rtpcr
use
ftd
resp
kit
fast
track
diagnost
silema
malta
kit
detect
follow
respiratori
pathogen
influenza
b
virus
coronavirus
cov
human
parainfluenza
virus
hpiv
human
metapneumoviru
ab
hmpv
rhinoviru
respiratori
syncyti
viru
rsv
ab
adenoviru
enteroviru
human
parechoviru
hpev
bocaviru
mycoplasma
pneumonia
viru
mini
kit
use
nucleic
acid
extract
quiagen
threshold
cycl
valu
consid
posit
result
rtpcr
indic
instruct
manual
two
experienc
radiologist
n
k
blind
clinic
inform
independ
review
highresolut
comput
tomographi
ct
scan
observ
ask
presenc
find
consolid
ggo
distribut
halo
sign
invert
halo
sign
cavit
centrilobular
nodul
mass
treeinbud
sign
intralobular
reticul
honeycomb
diffus
bronchial
wall
thicken
pleural
effus
pneumothorax
mediastin
hilar
lymphadenopathi
minim
diamet
mm
cardiomegali
patholog
find
review
pathologist
novemb
multidisciplinari
diagnosi
final
diagnosi
establish
base
laboratori
patholog
radiolog
find
pcr
result
clinic
cours
review
panel
compos
pulmonari
physician
n
n
k
radiologist
k
n
pathologist
multidisciplinari
diagnosi
viral
pneumonia
made
base
posit
viru
pcr
result
compat
clinic
cours
histolog
radiolog
find
contrast
consid
viru
colon
occur
patient
show
find
unlik
indic
viral
pneumonia
altern
diagnosi
made
review
panel
present
studi
patient
diagnosi
afop
cop
chronic
eosinophil
pneumonia
cep
classifi
categori
overlap
histolog
pattern
diagnost
criteria
establish
guidelin
also
consid
multidisciplinari
diagnosi
caus
microorgan
pneumonia
defin
use
convent
method
report
previous
control
balf
sampl
patient
chronic
pulmonari
diseas
sever
month
year
onset
chronic
hypersensit
pneumon
sarcoidosi
fibrot
nonspecif
interstiti
pneumonia
ip
desquam
interstiti
pneumonia
connect
tissu
diseaserel
ild
ctdild
n
recurr
relaps
cop
radiationprim
organ
pneumonia
op
without
acut
symptom
analyz
viru
pcr
test
viru
colon
defin
result
viru
pcr
test
posit
patient
diseas
viral
pneumonia
diagnos
multidisciplinari
diagnosi
treatment
failur
defin
persistencereappear
fever
symptom
hemodynam
instabl
develop
worsen
respiratori
failur
torr
satur
radiograph
progress
appear
new
infecti
foci
describ
previou
report
wherea
treatment
consid
effect
base
improv
subject
feel
oxygen
chest
imag
find
case
satisfi
definit
treatment
failur
studi
approv
ethic
committe
saitama
cardiovascular
respiratori
center
demograph
characterist
laboratori
measur
time
present
compar
viral
pneumonia
nonvir
pneumonia
group
use
student
ttest
continu
variabl
fisher
exact
test
categor
variabl
interobserv
reliabl
radiolog
find
evalu
use
kappa
coeffici
defin
poor
slight
fair
moder
substanti
almost
perfect
twotail
p
valu
consid
indic
statist
signific
statist
analys
perform
use
sa
softwar
program
version
sa
institut
cari
usa
differenti
diagnos
patient
present
consid
respiratori
physician
includ
sixti
patient
pcrposit
among
patient
final
rediagnos
diseas
viral
pneumonia
fig
six
patient
pulmonari
shadow
relaps
sever
time
taper
corticosteroid
postdischarg
followup
histolog
radiolog
find
clinic
cours
compat
op
patient
final
diagnos
cop
radiationprim
op
balf
eosinophilia
found
one
patient
patient
chest
ct
show
pulmonari
consolid
interlobular
septal
thicken
pleural
effus
sever
day
onset
symptom
patient
expos
smoke
find
compat
acut
eosinophil
pneumonia
final
diagnos
includ
viral
pneumonia
patient
diseas
viral
pneumonia
patient
unclassifi
ip
afop
cop
cep
radiationprim
op
breast
cancer
acut
eosinophil
pneumonia
acut
hp
ctdild
polymyos
dermatomyos
amyopath
dermatomyos
antibodi
antisynthetas
syndrom
rheumatoid
arthriti
dild
pneumonia
due
unknown
pathogen
n
patient
final
diagnosi
viral
pneumonia
diagnos
discharg
copcepafop
n
aip
ctdild
unclassifi
ip
pneumonia
dild
rate
final
diagnosi
viral
pneumonia
made
diagnosi
discharg
follow
aip
afop
cop
among
control
balf
sampl
obtain
patient
chronic
lung
diseas
patient
posit
viral
pcr
result
hpev
patient
sarcoidosi
rhinoviru
patient
sarcoidosi
rhinoviru
patient
fibrot
nonspecif
ip
five
patient
intub
mechan
ventil
underw
bal
frequent
detect
viru
patient
viral
pneumonia
cov
n
follow
hpev
rsv
rhinoviru
influenza
viru
hmpv
hpiv
adenoviru
tabl
combin
viral
infect
found
patient
includ
virus
influenza
viruscov
influenza
viru
hpiv
influenza
virusrsv
influenza
viru
hmpv
rvhpev
rvcov
rvhmpv
cov
number
case
viru
infect
diagnos
month
higher
winter
month
lower
summer
month
fig
median
rang
durat
onset
symptom
admiss
patient
viral
pneumonia
day
except
patient
corticosteroid
prescrib
local
physician
clinic
symptom
radiolog
find
laboratori
find
progress
patient
show
respiratori
failur
symptom
experienc
patient
list
tabl
sore
throat
fever
frequent
found
patient
viral
pneumonia
diseas
durat
onset
symptom
admiss
maximum
bodi
temperatur
differ
group
statist
signific
extent
median
rang
white
blood
cell
count
creactiv
protein
crp
valu
mm
mgdl
signific
differ
white
blood
cell
count
serum
procalcitonin
valu
patient
viral
pneumonia
diseas
tabl
serum
liver
transaminas
crp
valu
higher
patient
viral
pneumonia
diseas
tabl
fraction
eosinophil
balf
lower
patient
viral
pneumonia
diseas
nasopharyng
rapid
diagnost
test
rdt
perform
patient
influenzaassoci
pneumonia
test
neg
chest
ct
find
reveal
patient
viral
pneumonia
show
consolid
ggo
tabl
none
case
show
cavit
treeinbud
appear
halo
sign
consolid
ggo
bilater
patient
respect
fig
consolid
affect
lobe
ggo
affect
lobe
tabl
invert
halo
sign
found
patient
interobserv
reliabl
ct
scan
determin
presenc
intralobular
reticul
distribut
consolid
ggo
poor
slight
fair
determin
find
tabl
twentyf
patient
underw
transbronchi
lung
biopsi
tblb
underw
videoassist
lung
biopsi
histolog
sampl
show
intralumin
organ
alveol
character
thicken
alveolar
septa
infiltr
inflammatori
cell
alveolar
septa
n
intraalveolar
hemorrhag
fibrin
exud
n
fig
admiss
patient
viral
pneumonia
receiv
antibiot
eleven
patient
show
earli
treatment
failur
worsen
condit
patient
show
earli
late
treatment
failur
two
patient
receiv
effect
corticosteroid
therapi
admiss
condit
patient
becam
wors
antibiot
treatment
remain
patient
receiv
antibiot
corticosteroid
admiss
refer
hospit
condit
worsen
none
patient
receiv
neuraminidas
inhibitor
ni
admiss
admiss
patient
receiv
antibiot
plu
macrolid
fluoroquinolon
without
antibiot
other
antibiot
administ
patient
admiss
antibiot
treatment
administ
local
physician
fail
six
patient
influenzaassoci
pneumonia
receiv
ni
day
onset
initi
symptom
three
patient
ni
corticosteroid
start
simultan
patient
improv
patient
ni
start
without
corticosteroid
day
onset
symptom
ni
effect
patient
patient
howev
ni
administ
day
onset
patient
show
earli
treatment
failur
switch
corticosteroid
therapi
day
effect
patient
receiv
ni
receiv
corticosteroid
therapi
effect
th
day
respect
onset
symptom
pulmonari
shadow
two
patient
receiv
corticosteroid
ni
improv
spontan
followup
among
patient
suffer
viral
pneumonia
due
noninfluenza
virus
corticosteroid
antibiot
administ
patient
median
rang
day
onset
symptom
two
patient
die
corticosteroid
therapi
effect
one
patient
howev
patient
experienc
repeat
episod
aspir
pneumonia
caus
condit
deterior
death
patient
show
earli
late
treatment
failur
corticosteroid
therapi
caus
progress
deterior
patient
condit
death
patient
receiv
antibiot
without
corticosteroid
surviv
viral
infect
detect
approxim
half
patient
acut
progress
lung
diseas
requir
bal
differenti
diagnosi
surprisingli
half
patient
viral
pneumonia
misdiagnos
type
ild
discharg
patient
viral
pneumonia
receiv
antibiot
respond
poorli
guidelin
recommend
consid
viral
pneumonia
nonrespond
antibiot
howev
respiratori
physician
frequent
misdiagnos
viral
pneumonia
ild
suspect
ild
result
suggest
import
includ
viral
pneumonia
differenti
diagnosi
patient
acut
progress
diseas
suggest
ild
sever
symptom
laboratori
find
report
suggest
pure
viral
pneumonia
oppos
bacteri
pneumonia
less
product
cough
lower
peripher
white
blood
cell
count
lower
procalcitonin
crp
level
higher
serum
creatin
kinas
valu
studi
compar
viral
pneumonia
acut
diseas
found
sore
throat
fever
observ
significantli
frequent
patient
viral
pneumonia
diseas
laboratori
test
show
higher
liver
transaminas
crp
valu
lower
number
eosinophil
balf
patient
viral
pneumonia
diseas
studi
also
show
difficult
distinguish
viral
pneumonia
acut
ild
pneumonia
due
unknown
etiolog
use
procalcitonin
alon
although
procalcitonin
use
marker
discrimin
viral
bacteri
infect
convent
diagnost
test
respiratori
viral
infect
includ
cultur
serolog
direct
fluoresc
antibodi
stain
howev
method
limit
slow
turnaround
time
insuffici
sensit
although
pcr
techniqu
labor
intens
technic
demand
requir
special
laboratori
equip
high
sensit
studi
suggest
use
detect
viral
infect
nasopharyng
rdt
patient
primari
influenza
viral
pneumonia
neg
studi
support
low
sensit
nasopharyng
rdt
pandem
perform
rdt
use
balf
howev
pcr
test
use
balf
use
recommend
diagnosi
primari
influenza
viral
pneumonia
studi
patient
posit
pcr
result
consid
indic
colon
previou
adult
studi
virus
detect
asymptomat
patient
differenti
infect
colon
still
difficult
use
pcr
method
thu
physician
diagnos
patient
viral
infect
base
pcr
result
alon
studi
frequent
detect
viru
cov
line
find
previou
report
second
frequent
viru
viral
pneumonia
hpev
isol
patient
among
control
hpev
caus
gastroenter
respiratori
infect
children
sever
recent
larg
studi
cast
doubt
role
hpev
signific
caus
respiratori
diseas
howev
result
suggest
hpev
rare
adult
signific
role
viral
pneumonia
immunocompromis
patient
pneumonia
frequent
viru
cov
follow
rhinoviru
hpiv
present
studi
afop
cop
cep
found
frequent
misdiagnos
ild
variou
influenzaassoci
pneumonia
show
similar
ct
pattern
cop
afop
aip
report
previou
report
focus
primari
influenza
suggest
ct
find
patient
viral
pneumonia
compat
diagnosi
spectrum
ct
find
encount
viral
pneumonia
nonspecif
also
found
ild
physician
includ
viral
pneumonia
differenti
diagnosi
imag
pattern
suggest
diseas
addit
histolog
find
patient
viral
pneumonia
mostli
obtain
via
tblb
also
nonspecif
difficult
suspect
viral
pneumonia
basi
histolog
find
alon
patient
viral
pneumonia
treatment
mainli
support
care
efficaci
ni
partial
report
influenzaassoci
pneumonia
ni
effect
patient
recommend
ni
administ
within
hour
onset
symptom
howev
ni
administ
period
effect
patient
regard
treatment
viral
infect
influenza
viru
immunoglobulin
therapi
pegyl
rhinoviru
potenti
efficaci
palivizumab
rsv
ribavirin
guanosin
analogu
therapi
rsv
hmpv
cidofovir
nucleosid
analogu
cytidin
monophosph
adenoviru
infect
report
howev
efficaci
treatment
primari
viral
pneumonia
unknown
sever
case
requir
aggress
treatment
includ
antivir
therapi
howev
one
problem
found
viral
pneumonia
infrequ
caus
multipl
virus
similar
result
report
elsewher
may
use
physician
test
multipl
virus
simultan
consid
antivir
therapi
patient
present
studi
receiv
corticosteroid
therapi
misdiagnos
ild
use
corticosteroid
treatment
viral
pneumonia
controversi
corticosteroid
report
ineffect
treatment
rsv
children
howev
data
suggest
favor
effect
varicellazost
viru
combin
acyclovir
hantaviru
influenzaassoci
pneumonia
clinic
set
patient
influenzaassoci
pneumonia
corticosteroid
administ
without
ni
patient
effect
among
patient
viral
pneumonia
due
noninfluenza
virus
corticosteroid
administ
patient
surviv
howev
effect
patient
signific
corticosteroid
therapi
viral
pneumonia
address
futur
studi
present
studi
associ
sever
limit
first
nonrandom
observ
studi
level
confid
reduc
second
studi
carri
singl
center
result
may
applic
set
noteworthi
institut
specialist
physician
licens
japan
respiratori
societi
physician
judg
need
bal
thu
bia
term
patient
underw
bal
addit
requir
hospit
major
criterion
entri
studi
could
potenti
induc
spectrum
bia
sever
case
enrol
studi
third
may
incorpor
bia
review
panel
determin
final
diagnosi
like
classifi
case
viral
pneumonia
fever
sore
throat
present
fourth
investig
antibodi
titer
virus
acut
convalesc
phase
thu
number
case
viral
pneumonia
might
underestim
fifth
multidisciplinari
diagnos
made
without
videoassist
thoracoscop
surgeri
case
thu
patholog
find
may
fulli
evalu
sixth
viral
infect
may
miss
studi
limit
number
virus
screen
assay
final
possibl
detect
virus
upper
respiratori
tract
deni
use
bal
techniqu
avoid
concern
welldesign
prospect
studi
need
sampl
obtain
lower
respiratori
tract
exampl
via
intub
use
protect
specimen
brush
conclus
detect
viral
pneumonia
approxim
half
patient
respiratori
physician
frequent
suspect
acut
progress
ild
clinic
symptom
laboratori
find
diagnost
viral
pneumonia
result
suggest
signific
number
patient
viral
pneumonia
may
misdiagnos
ild
especi
afop
cop
cep
guidelin
recommend
consid
viral
pneumonia
nonrespond
antibiot
howev
import
includ
viral
pneumonia
differenti
diagnosi
acut
progress
case
suggest
ild
